Clinical trials
Type 1 diabetes clinical trials
An autoimmune condition where the body makes little or no insulin. We’re tracking 875 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07098663RecruitingPhase 2
Study of MKP10241 for weight loss and diabetes control
This study tests an investigational drug called MKP10241 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects blood sugar, weight, and overall safety. It may be an option if you have obesity or type 2 diabetes managed by diet and/or metformin.
Bayswater, VictoriaAges 18–60 - NCT07431359Recruiting
Mediterranean diet study for type 2 diabetes patients
This trial looks at what people with type 2 diabetes know about diet and how often they eat a Mediterranean diet. It aims to understand if this way of eating can help with diabetes management.
Peschiera del Garda, VeronaAges 18–80 - NCT06549400Enrolling by invitationPhase 3
Study on long-term safety of mexiletine for myotonic dystrophy
This study tests if a daily capsule of mexiletine is safe and helpful over 26 weeks for people with myotonic dystrophy type 1 or 2. It's for people who finished a previous related study and want to continue treatment.
LeuvenAges 16 years+ - NCT06542627Recruiting
Continuous glucose monitoring for diabetes and weight management
This study uses a continuous glucose monitor to help people with prediabetes or type 2 diabetes better manage their blood sugar and weight, and will test how well it works in a real-world workplace setting.
SeoulAges 19 years+ - NCT06846138Enrolling by invitation
Herbal supplement to help metformin work better and cause fewer side effects
This study tests a special herbal blend added to metformin to see if it helps reduce stomach problems and improves blood sugar control in people with type 2 diabetes. Researchers want to understand how the herbs affect the bacteria in your gut.
RigaAges 25–80 - NCT07187479Recruiting
Testing a new insulin approach for kidney disease and diabetes
This study tests a new approach to help your body use insulin better, which may improve blood sugar control and slow down kidney disease. It is for people with advanced chronic kidney disease and type 2 diabetes who are not yet on dialysis.
Phoenix, ArizonaAges 18 years+ - NCT06954090Enrolling by invitationPhase 4
Urine test to guide early treatment in type 2 diabetes
This study looks at whether a urine test can help doctors choose the right medicines earlier to prevent kidney and heart problems in people with type 2 diabetes. You may join if you have type 2 diabetes but no severe heart failure.
Herlev, Hajdú-BiharAges 18 years+ - NCT06600724Recruiting
Testing a placental tissue dressing for diabetic foot ulcers
This study tests a special wound dressing made from a placental tissue (called PpLHACM) plus standard care, compared to standard care alone, to help heal diabetic foot ulcers that have not healed with usual treatment. It is for people with diabetes who have a moderate-sized foot ulcer without infection or exposed bone.
Monroeville, PennsylvaniaAges 18 years+ - NCT05908812Recruiting
Testing how blood sugar control links to a hormone in type 2 diabetes
This study looks at whether better blood sugar control changes levels of a hormone called irisin in people with type 2 diabetes and obesity, including those with or without age-related muscle loss (sarcopenia). Your results may help researchers understand the body’s response to diabetes and could guide future treatment ideas.
BariAges 60 years+ - NCT05766735Recruiting
Lifestyle program to lower sugar spikes after meals
This trial studies whether a structured lifestyle program can reduce “sugar spikes” after meals in people with early type 2 diabetes. It may help by combining coaching, tracking, and meal/activity changes to improve blood sugar control.
Aurora, ColoradoAges 30–80 - NCT06336239Recruiting
Study of urine protein in people with heart disease and diabetes
This study looks at how common protein in the urine (albuminuria) is among people in China who have both type 2 diabetes and heart problems. It aims to understand the link between these conditions without testing a new treatment.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07083154RecruitingPhase 3
Testing a dual-action drug for diabetes and early memory loss
This study tests if a new type of diabetes drug that targets two natural hormones can help people with type 2 diabetes who also have early memory problems. If you have type 2 diabetes and mild cognitive impairment or mild dementia, this trial may offer a potential treatment option.
Changsha, HunanAges 50–75 - NCT06958302Recruiting
Diabetes Nerve Damage and Muscle Mass in Type 2 Diabetes
This study examines how nerve damage from diabetes (diabetic neuropathy) relates to muscle loss in people with type 2 diabetes. It aims to help understand and possibly prevent muscle weakness.
Cairo, AbbassiaAges 45 years+ - NCT07278115Recruiting
Gastric bypass with or without nerve-cutting for diabetes
This study compares two types of surgery for people with type 2 diabetes who also have obesity: gastric bypass alone versus gastric bypass plus a procedure called truncal vagotomy (cutting a nerve to the stomach). It aims to see which approach leads to better diabetes remission.
Athens, AtticaAges 18–68 - NCT06649162Recruiting
Fatty liver risk in type 2 diabetes and new combo therapy
This study is looking at how often people with type 2 diabetes also have fatty liver disease, and whether a new combination medication (dapagliflozin and pioglitazone) can help manage both conditions.
Andong, Gyeongsangbuk-doAges 19 years+ - NCT07502508RecruitingPhase 2
Icovamenib for type 2 diabetes with Ozempic
This trial tests an investigational pill called icovamenib for people with type 2 diabetes who are already on Ozempic but still have high blood sugar. The goal is to see if adding icovamenib helps lower blood sugar more safely.
Birmingham, AlabamaAges 18–70 - NCT05770687Recruiting
Testing diabetes heart medicine soon after a heart attack
This study looks at how starting an SGLT2 inhibitor (a diabetes medicine) around the time of a heart attack affects heart outcomes and heart muscle changes over time. It may help you and your care team understand whether this timing is beneficial after a PCI procedure.
SeoulAges 19 years+ - NCT06863532Recruiting
Comparing two add-on treatments for type 2 diabetes
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
Hangzhou, ZhejiangAges 18–74 - NCT06925334Enrolling by invitationPhase 4
Comparing a new insulin combo with premixed insulin for type 2 diabetes
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
Beijing, Beijing MunicipalityAges 18–75 - NCT05651919Recruiting
Blood test study to understand diabetic heart weakness
This study measures immune cells from your blood to find markers (biomarkers) that may explain or predict diabetic cardiomyopathy, a type of heart condition linked to diabetes. You may benefit mainly by being closely monitored and contributing to research that could improve future diagnosis or risk tracking.
BronAges 40–85 - NCT05687968Recruiting
Using phone food logs to improve diabetes care
This study tests an approach to diabetes care that relies on you recording what you eat using a smartphone. It may help the research team learn how food patterns relate to blood sugar and how to improve care.
TaipeiAges 20 years+ - NCT06384313Recruiting
Butyrate supplement for preventing diabetes
This study tests if a special type of fat (butyrate) can help prevent diabetes in people who are overweight and have early signs of blood sugar problems. You would take a supplement for several weeks to see if it improves how your body handles sugar.
Maastricht, LimburgAges 20–70 - NCT07066891Recruiting
AI insulin dose prediction for type 2 diabetes
This study tests an artificial intelligence system that helps predict the right insulin dose for people with type 2 diabetes who are using an insulin pump in the hospital. The goal is to make blood sugar control safer and more accurate.
Guangzhou, GuangdongAges 18–75 - NCT07171281Recruiting
Timing meals to improve blood sugar and heart health
This study tests whether eating at specific times of day can help control blood sugar and improve heart health in people with prediabetes or type 2 diabetes. It compares two different eating schedules to see which works better.
NuthetalAges 18–75
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes?
- Yes. Clin2 currently lists 875 recruiting type 1 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.